Department of Health- Abu Dhabi reviews future opportunities for clinical research

Department of Health- Abu Dhabi reviews future opportunities for clinical research

ABU DHABI- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate of Abu Dhabi, has reviewed future opportunities for clinical research in the Emirate at a workshop titled "Clinical Research in Abu Dhabi Healthcare and Biopharmaceutical Hub".The workshop brought together 29 healthcare experts and scientists from DoH, leading healthcare icons, members of the Pharmaceutical Research and Manufacturers Association Gulf in addition to representatives from several leading clinical research institutions from around the world.Participants discussed a range of topics related to clinical research, including investment trends in the field, the most prominent developments in Abu Dhabi, innovative biopharmaceutical industries, guidelines and regulatory incentives for clinical research, as well as the future of clinical research in the Emirate and potential local, regional and global cooperation opportunities.During the workshop, DoH highlighted the advantageous aspects of Abu Dhabi as a locale for clinical research trials including the facilities provided to pharmaceutical companies and the highly accelerated review timelines that take place within just 8 to 15 days. These timelines are among the fastest in the world today. Additionally, the Emirate has been dedicated to providing world-class research facilities and protecting distinguished intellectual property.Dr. Jamal Mohammed Alkaabi,